Comparison of LMA-Fastrach and I-gel for Blind Tracheal Intubation.
NCT ID: NCT01007370
Last Updated: 2017-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2010-03-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our hypothesis is that the use of the I-gel supraglottic airway will result in a higher first attempt success rate of blind tracheal intubation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does the Use of the GlideRite® Endotracheal Tube in Combination With the I-gel® Improve Intubation Success Rate?
NCT01265862
Comparison Study of Two Supraglottic Airway Devices Used for Patients Under General Anesthesia
NCT01001078
ILMA Fastrach Versus I-gel for Fiberoptic Tracheal Intubation
NCT00888875
Comparison of CTrach, Intubating Laryngeal Mask Airway (ILMA) and I-gel for Tracheal Intubation
NCT00983229
Comparison of Efficiency Between I-gel Blind Intubation and I-gel Bronchoscopic Intubation During Resuscitation
NCT02411422
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The LMA-Fastrach is designed to provide a conduit for blind or fiberoptically guided tracheal intubations. However, the success rate of tracheal intubation on the first attempt through this device varies between 50 and 87%.
The I-gel is a newer device for airway management which, with its wide bore, allows direct passage of a tracheal tube. Recent studies suggest that the I-gel is easy to insert and that limited experience is needed before a high success insertion rate is obtained.
In this prospective and randomized study, we will evaluate the performance of both devices for tracheal intubation in patients undergoing elective surgery under general anesthesia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LMA-Fastrach
* Induction of general anesthesia with 1,5-2,5 mg/kg propofol and 1-3 mcg/kg fentanyl and neuromuscular relaxation with 0,6 mg/kg of rocuronium.
* Direct laryngoscopy, evaluation of laryngeal view grade according to Cormack-Lehane classification
* Insertion of LMA-Fastrach (sizes 3,4 or 5), establishment of ventilation
* Evaluation of glottic view through LMA-Fastrach using fibrescope (one out of ten patients)
* Tracheal intubation through the LMA-Fastrach
* With the endotracheal tube in place, the anaesthesiologist will proceed to the removal of supraglottic device
Tracheal intubation
Tracheal intubation through a supraglottic airway device(LMA-Fastrach).
I-gel
* Induction of general anesthesia with 1,5-2,5 mg/kg propofol and 1-3 mcg/kg fentanyl and neuromuscular relaxation with 0,6 mg/kg of rocuronium.
* Direct laryngoscopy, evaluation of laryngeal view grade according to Cormack-Lehane classification
* Insertion of I-gel (sizes 3,4 or 5), establishment of ventilation
* Evaluation of glottic view through I-gel using fibrescope (one out of ten patients)
* Tracheal intubation through the I-gel
* With the endotracheal tube in place, the anaesthesiologist will proceed to the removal of supraglottic device
Tracheal intubation
Tracheal intubation through a supraglottic airway device(I-gel).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tracheal intubation
Tracheal intubation through a supraglottic airway device(LMA-Fastrach).
Tracheal intubation
Tracheal intubation through a supraglottic airway device(I-gel).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA physical status 1-3
* Patients undergoing elective surgery under general anesthesia, requiring endotracheal intubation
Exclusion Criteria
* Contraindications to muscle relaxation
* Anticipated or known difficult intubation or ventilation
* Patients with limited mouth opening (less than 2 cm)
* Patients at increased risk of aspiration, or having an history of symptomatic gastroesophageal reflux or hiatal hernia.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathalie Massicotte, MD, FRCPC
Role: PRINCIPAL_INVESTIGATOR
Centre hospitalier de l'Université de Montréal (CHUM)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier de l'Université de Montréal-Hôpital Notre-Dame
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NM 2010-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.